Sign in
CompletedPhase 1

Development of a Robotic Ankle Assist Device

Key facts

Who runs it
BiOMOTUM, Inc.
Where
Flagstaff, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 1
People taking part
31 people enrolled
Started
1 Nov 2020
Ended
31 Aug 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Robotic Ankle Assist Device (RAAD)
Record updated
4 April 2025

Who can take part

Age
8 years to 21 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Diagnosis of cerebral palsy. Any sex, race, ethnicity or socioeconomic status. GMFCS level I, II, or II. Ability to walk for at least 6 minutes (assisted or unassisted). Age between 8-18 years. Height/weight/BMI between the 5th - 95th percentile of children with CP
  • Able to understand and follow simple directions. Able to complete 5 heel raises with minimal assistance (balance only). At least 20 degrees of passive ankle plantar flexion range of motion

Who cannot take part

  • Orthopedic surgery completed in the prior 12-months. Current enrollment in a conflicting research study
  • Knee extension or ankle dorsiflexion contractures greater than 15 degrees. Health condition or diagnosis other than CP that would affect safe participation

Where in United States

  • Northern Arizona UniversityFlagstaff, United States

About the trial

What the trial wants to find out

The overall objectives of this work is to establish feasibility of a robotic ankle assist device (RAAD) to improve mobility in free-living settings and to establish the RAAD as an effective tool to provide increased dose and precision of targeted ankle therapy.

Read full original descriptionShow less

The first specific goal is to assess the benefits of repeated gait training with RAAD assistance. Individuals with CP will participate in a 4-week assistance intervention and mobility outcomes will be quantified pre and post intervention.

The second specific goal is to separately assess the benefits of repeated gait training with RAAD resistance. Individuals with CP will participate in a 4-week resistance intervention and mobility outcomes will be quantified pre and post intervention.

Assessed separately, it is hypothesized that both assistance and resistance training will improve mobility outcomes.

The 2 groups in the trial

  • Therapist supervised assistance trainingTreatment being tested

    Assistance training with the RAAD under therapist supervision.

    Treatment: Robotic Ankle Assist Device (RAAD)

  • Therapist supervised resistance trainingTreatment being tested

    Resistance training with the RAAD under therapist supervision.

    Treatment: Robotic Ankle Assist Device (RAAD)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Development of a Robotic Ankle Assist Device to Improve Mobility in Individuals With Movement Disorders
Record updated
4 April 2025